Today's Top Gainer
| SYMBOL | CMP | Chg (%) |
|---|---|---|
Note:Top Gainer - Nifty 50 More
Bafna Pharmaceuticals Ltd Financials
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 18.90 | (24) | (13) | (47) |
| Op profit growth | (12) | (1,225) | (103) | (177) |
| EBIT growth | (13) | 276 | (111) | 42.40 |
| Net profit growth | (13) | 38.70 | (327) | 340 |
| Profitability ratios (%) | ||||
| OPM | (6.60) | (8.90) | 0.61 | (18) |
| EBIT margin | (10) | (14) | (2.80) | 22.90 |
| Net profit margin | (22) | (30) | (16) | 6.32 |
| RoCE | (7.20) | (6.60) | (1.60) | 13.60 |
| RoNW | (10) | (9.70) | (5.40) | 2.20 |
| RoA | (3.90) | (3.60) | (2.40) | 0.94 |
| Per share ratios () | ||||
| EPS | -- | -- | -- | 3.33 |
| Dividend per share | -- | -- | -- | -- |
| Cash EPS | (8.80) | (13) | (10) | 0.10 |
| Book value per share | 16 | 22.90 | 31 | 38.50 |
| Valuation ratios | ||||
| P/E | -- | -- | -- | 8.92 |
| P/CEPS | (3.20) | (2.30) | (3) | 289 |
| P/B | 1.75 | 1.29 | 0.97 | 0.77 |
| EV/EBIDTA | (29) | (29) | 53.50 | 4.28 |
| Payout (%) | ||||
| Dividend payout | -- | -- | -- | -- |
| Tax payout | 14.90 | (4.40) | (1.20) | 1.71 |
| Liquidity ratios | ||||
| Debtor days | 185 | 342 | 335 | 348 |
| Inventory days | 64.80 | 93 | 69.50 | 81.30 |
| Creditor days | (116) | (159) | (172) | (133) |
| Leverage ratios | ||||
| Interest coverage | 1.12 | 0.77 | 0.18 | (1.70) |
| Net debt / equity | 1.15 | 1.87 | 1.35 | 0.92 |
| Net debt / op. profit | (8.60) | (14) | 151 | (3.70) |
| Cost breakup () | ||||
| Material costs | (50) | (80) | (77) | (84) |
| Employee costs | (9.70) | (10) | (8.20) | (11) |
| Other costs | (47) | (19) | (14) | (23) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Revenue | 77.20 | 65 | 85.30 | 97.70 |
| yoy growth (%) | 18.90 | (24) | (13) | (47) |
| Raw materials | (38) | (52) | (66) | (82) |
| As % of sales | 49.60 | 79.90 | 77.40 | 83.60 |
| Employee costs | (7.50) | (6.80) | (7) | (11) |
| As % of sales | 9.68 | 10.50 | 8.19 | 11 |
| Other costs | (37) | (12) | (12) | (23) |
| As % of sales | 47.30 | 18.50 | 13.80 | 23.40 |
| Operating profit | (5.10) | (5.80) | 0.52 | (18) |
| OPM | (6.60) | (8.90) | 0.61 | (18) |
| Depreciation | (4) | (4.20) | (4.90) | (6) |
| Interest expense | (6.90) | (11) | (13) | (13) |
| Other income | 1.29 | 1.14 | 1.98 | 46 |
| Profit before tax | (15) | (20) | (15) | 8.90 |
| Taxes | (2.20) | 0.90 | 0.18 | 0.15 |
| Tax rate | 14.90 | (4.40) | (1.20) | 1.71 |
| Minorities and other | -- | -- | 1.11 | -- |
| Adj. profit | (17) | (19) | (14) | 9.01 |
| Exceptional items | -- | -- | -- | (2.80) |
| Net profit | (17) | (19) | (14) | 6.18 |
| yoy growth (%) | (13) | 38.70 | (327) | 340 |
| NPM | (22) | (30) | (16) | 6.32 |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
| Profit before tax | (15) | (20) | (15) | 8.90 |
| Depreciation | (4) | (4.20) | (4.90) | (6) |
| Tax paid | (2.20) | 0.90 | 0.18 | 0.15 |
| Working capital | (62) | (54) | (34) | -- |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | (83) | (78) | (54) | 3.07 |
| Capital expenditure | (8.60) | (6.30) | (11) | -- |
| Free cash flow | (91) | (84) | (65) | 3.07 |
| Equity raised | 81.90 | 92.30 | 103 | 100 |
| Investments | -- | 16.90 | 16.90 | -- |
| Debt financing/disposal | (39) | (18) | (28) | -- |
| Dividends paid | -- | -- | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | (48) | 6.92 | 28 | 103 |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Equity capital | 23.70 | 23.70 | 22.70 | 18.70 |
| Preference capital | -- | -- | -- | -- |
| Reserves | (4.60) | 14.30 | 20 | 39.10 |
| Net worth | 19.10 | 37.90 | 42.70 | 57.80 |
| Minority interest | ||||
| Debt | 46.20 | 46.50 | 82.40 | 80.50 |
| Deferred tax liabilities (net) | 6.18 | 5.11 | 2.92 | 3.82 |
| Total liabilities | 71.30 | 88.90 | 127 | 142 |
| Fixed assets | 37.10 | 44.90 | 48.60 | 52.60 |
| Intangible assets | ||||
| Investments | -- | -- | 16.90 | 16.90 |
| Deferred tax asset (net) | -- | -- | -- | -- |
| Net working capital | 31.50 | 41 | 59.30 | 69.80 |
| Inventories | 9.28 | 10.70 | 16.70 | 16.40 |
| Inventory Days | -- | 50.40 | 94.10 | 70.10 |
| Sundry debtors | 24.80 | 24.30 | 53.80 | 68 |
| Debtor days | -- | 115 | 302 | 291 |
| Other current assets | 45.60 | 55.60 | 39.60 | 36.10 |
| Sundry creditors | (40) | (29) | (24) | (38) |
| Creditor days | -- | 135 | 134 | 161 |
| Other current liabilities | (8.70) | (21) | (27) | (13) |
| Cash | 2.71 | 2.95 | 2.66 | 2.71 |
| Total assets | 71.30 | 88.90 | 127 | 142 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Jun-2019 | - | - | - | - |
|---|---|---|---|---|---|
| Gross Sales | 6.85 | -- | -- | -- | -- |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 6.85 | -- | -- | -- | -- |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 0.30 | -- | -- | -- | -- |
| Total Income | 7.15 | -- | -- | -- | -- |
| Total Expenditure ** | 9.72 | -- | -- | -- | -- |
| PBIDT | (2.60) | -- | -- | -- | -- |
| Interest | 0.13 | -- | -- | -- | -- |
| PBDT | (2.70) | -- | -- | -- | -- |
| Depreciation | 1.02 | -- | -- | -- | -- |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- |
| Deferred Tax | (1.60) | -- | -- | -- | -- |
| Reported Profit After Tax | (2.10) | -- | -- | -- | -- |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | (2.10) | -- | -- | -- | -- |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | (2.10) | -- | -- | -- | -- |
| EPS (Unit Curr.) | (0.90) | -- | -- | -- | -- |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 23.70 | -- | -- | -- | -- |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | (38) | -- | -- | -- | -- |
| PBDTM(%) | (39) | -- | -- | -- | -- |
| PATM(%) | (31) | -- | -- | -- | -- |
